Meghan Higman, MD, PhD
Areas of Expertise:
Pediatric bone marrow transplantation
Biology of Hodgkin lymphoma
Education and Training:
MD - State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY
PhD - State University of New York at Buffalo, Buffalo, NY
Children’s Hospital of Pittsburgh, Pittsburgh, PA
Pediatrics, American Board of Pediatrics
Pediatric Hematology-Oncology, American Board of Pediatrics
Johns Hopkins University, Baltimore, MD
- AHOD0031: A phase III study of dose-intensive therapy for intermediate risk hodgkin lymphoma: A report from the children's oncology group. Blood 2010; 116(21):766 .
- Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). Blood 2011; 118(21):4570 .